Nucleic Acid Amplification and Detection Analyzer

USTAR BIOTECHNOLOGIES(HANGZHOU)LTD

China

Ustar Biotechnologies (Hangzhou) Ltd., founded in 2005, specializes in innovative point-of-care molecular diagnostics (POCT) technology and products. The company holds over 50 international and domestic patents (38 granted) and received the National Science and Technology Progress Second Prize. Their COVID-19 nucleic acid rapid test kit was the first domestic molecular POCT product approved by NMPA, featuring integrated magnetic bead extraction and nucleic acid amplification with detection limit ≤200 copies/ml.